Pain management in patients with vascular disease

Slides:



Advertisements
Similar presentations
Pathophysiology of Pain
Advertisements

1 Chapter 54 Pain Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Synaptic Transmission Chapter 4 Pages Chemical Synapses  Most synapses in the brain are chemical. Electronically coupled gap junction synapses.
Pain - Basic Science Implications for Analgesia & Analgesics Neural Plasticity Research Group Department of Anesthesia and Critical Care Massachusetts.
Pain and Analgesia PAIN IS
Assisted Professor Basic Science Department 2012
Somatosensory System and Pain Prof. Marshall Devor, Ph.D. Dept. of Cell & Animal Biology and Center for Research on Pain Institute of Life Sciences Hebrew.
Chapter 83: Bone Cancer and Pain Mary Ann C. Sabino and Denis R. Clohisy.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Therapeutic Restoration of Spinal Inhibition via.
Nervous System.
© UWCM/SONMS/Pain/MJohn
Peter J. Barnes, FRS, FMedSci 
W5D3H3: Sensory Receptors
Fig. 2. The sympathetic nervous system (SNS) and pain
ION CHANNELS AS DRUG TARGETS & CONTROL OF RECEPTOR EXPRESSION
Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases 
Introduction to the pharmacology of CNS drugs
Neurotransmitters Domina Petric, MD.
The inflammasome in liver disease
Neurovascular Aspects of Skin Neurogenic Inflammation
The Angiotensin II Type 2 Receptor for Pain Control
Neuroinflammation and the generation of neuropathic pain
Mechanisms and Therapeutic Relevance of Neuro-immune Communication
Emerging Concepts in the Neurobiology of Chronic Pain: Evidence of Abnormal Sensory Processing in Fibromyalgia  Robert M. Bennett, M.D.  Mayo Clinic Proceedings 
The role of viruses in acute exacerbations of asthma
Mechanisms of inflammatory pain
Cooling the Itch via TRPM8
Mechanisms of Neuropathic Pain
Christian A. von Hehn, Ralf Baron, Clifford J. Woolf  Neuron 
ION CHANNELS AS DRUG TARGETS &
Role of COX-2 Inhibitors in the Evolution of Acute Pain Management
Therapeutic pipeline for atopic dermatitis: End of the drought?
When does acute pain become chronic?
Treatment of postherpetic neuralgia: a review of therapeutic options
Cellular and Molecular Mechanisms of Pain
(A) Diagram to illustrate some of the processes leading to central sensitization. (A) Diagram to illustrate some of the processes leading to central sensitization.
TRPs in Our Senses Current Biology
Transmitting Pain and Itch Messages: A Contemporary View of the Spinal Cord Circuits that Generate Gate Control  João Braz, Carlos Solorzano, Xidao Wang,
Nat. Rev. Cardiol. doi: /nrcardio
dr. Henny Anggraini Sadeli SpS(K)
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch  P. Anand, K. Bley 
M. Chincholkar  British Journal of Anaesthesia 
Mechanisms of neuropathic pain
Pro-endometriotic niche in endometriosis
Volume 32, Issue 3, Pages (November 2001)
H. Zhao, A. Alam, Q. Chen, M. A. Eusman, A. Pal, S. Eguchi, L. Wu, D
Non-canonical Signaling, the Hidden Life of Ligand-Gated Ion Channels
A Neuropeptide Courier for δ-Opioid Receptors?
Trans-Synaptic Plasticity: Presynaptic Initiation, Postsynaptic Memory
Mechanisms Underlying Inflammation in Neurodegeneration
Anti-nociceptive effects of caloric restriction on neuropathic pain in rats involves silent information regulator 1  Y. Liu, Y. Ni, W. Zhang, Y.E. Sun,
The Two Sides of Hippocampal Mossy Fiber Plasticity
A TR(I)P to Pruritus Research: Role of TRPV3 in Inflammation and Itch
David A. Lewis, Allison A. Curley, Jill R. Glausier, David W. Volk 
Current Challenges in Glia-Pain Biology
Volume 22, Issue 17, Pages R705-R711 (September 2012)
Volume 88, Issue 4, Pages (November 2015)
SCOPing out Proteases in Long-Term Memory
Signaling Pathways in Sensitization: Toward a Nociceptor Cell Biology
How does brain insulin resistance develop in Alzheimer's disease?
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Nociceptors—Noxious Stimulus Detectors
Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert  Andreas Reiner, Joshua Levitz  Neuron  Volume.
SCOPing out Proteases in Long-Term Memory
A representation of the central spinal and peripheral changes that accompany neuropathy. A representation of the central spinal and peripheral changes.
Sodium channels and the synaptic mechanisms of inhaled anaesthetics
Opening a “Wide” Window onto Taste Signal Transmission
Increasingly Irritable and Close to Tears: TRPA1 in Inflammatory Pain
Airway smooth muscle: An immunomodulatory cell
Volume 20, Issue 1, Pages R31-R36 (January 2010)
Presentation transcript:

Pain management in patients with vascular disease M. Seretny, L.A. Colvin  British Journal of Anaesthesia  Volume 117, Pages ii95-ii106 (January 2016) DOI: 10.1093/bja/aew212 Copyright © 2016 The Author(s) Terms and Conditions

Fig 1 Mediators of inflammatory pain. Local inflammatory cells and infiltrating cells release mediators including pro-inflammatory cytokines [tumour necrosis factor (TNF; formerly known as TNFα), bradykinin, prostaglandins, interleukin-1β (IL-1β), and interleukin-6 (IL-6)], H+, ATP, nerve growth factors (NGFs), and pro-inflammatory chemokines [CC-chemokine ligand 2 (CCL2), CXC-chemokine ligand 1 (CXCL1) and ), CXC-chemokine ligand 5 (CXCL5)]. Receptors for these inflammatory mediators, including G-protein-coupled receptors (GPCRs), ionotropic receptors, and tyrosine kinase receptors, are expressed on nociceptive neurones. Stimulation causes generation of second messengers, such as cyclic AMP and Ca2+, and downstream activation of kinases [protein kinase A (PKA), protein kinase C (PKC), extracellular signal-regulated kinase (ERK), phosphoinositide 3-kinase (PI3K), calcium/calmodulin-dependent protein kinase (CaMK), and the mitogen-activated protein kinases (MAPKs), p38 MAPK, and JUN N-terminal kinase (JNK)]. Activation of these kinases causes peripheral sensitization by modulating transduction molecules (e.g. transient receptor potential cation channel subfamily A member 1 (TRPA1) and TRPV1) and conduction (voltage-gated sodium channels Nav1.7–1.9). Activated nociceptors release substance P and calcitonin gene-related peptide (CGRP), involved in the generation of neurogenic inflammation and (CGRP) regulation of lymphadenopathy. Bacterial infection with Staphylococcus aureus induces neuronal hyperexcitability by releasing bacterial N-formylated peptides (FPs) and the formation of the pore-forming toxin α-haemolysin (α-HL). The bacteria can also directly activate nociceptors. 4-HNE, 4-hydroxynonenal; 5,6-EET, 5,6- epoxyeicosatrienoic acid; ASIC, acid-sensing ion channel; FPR1, formyl peptide receptor 1; HETE, 5-hydroxyeicosatetraenoic acid; HMGB1, high mobility group protein B1; P2X3, P2X purinergic receptor 3; PGE2, prostaglandin E2; RTK, receptor tyrosine kinase. Figure reproduced with permission from Macmillan Publishers Ltd.41 British Journal of Anaesthesia 2016 117, ii95-ii106DOI: (10.1093/bja/aew212) Copyright © 2016 The Author(s) Terms and Conditions

Fig 2 Mechanisms of neuropathic pain. (a) Primary afferent pathways connecting to the spinal cord dorsal horn. Nociceptive C fibres (red) terminate in upper laminae (yellow neurone), whereas non-nociceptive myelinated A fibres project to deeper laminae. Second-order neurones (WDR type) receive direct nociceptive input, synaptic input, and multisynaptic input from myelinated A fibres (non-noxious information; blue neurone system). Microglia (grey cell) facilitate synaptic transmission. GABAergic interneurones (green neurone) normally exert inhibitory synaptic input on the second-order neurone. Descending modulatory systems synapse at the second-order neurone (only the inhibitory projection; green descending terminal). (b) Peripheral changes underpinning peripheral sensitization at primary afferent neurones after damage. Note that some axons are damaged and degenerate (axons 1 and 3), whereas some remain intact and connected to the peripheral end organ (skin; axons 2 and 4). Expression of sodium channels is increased on damaged neurones (axon 3). Products such as nerve growth factor are released in the vicinity of spared fibres (arrow). These trigger the expression of channels and receptors (e.g. sodium channels, TRPV1 receptors, and adrenoreceptors) on uninjured fibres. (c) Spontaneous activity in C nociceptors induces spinal cord hyperexcitability (central sensitization of second-order nociceptive neurones; star in yellow neurone). These cause input from mechanoreceptive A fibres (blue neurone system; light touching and punctate stimuli) to be perceived as pain (dynamic and punctate mechanical allodynia; + indicates gating at synapse). Several presynaptic (opioid receptors and calcium channels) and postsynaptic molecular structures (glutamate receptors, AMPA/kainate receptors, sodium/5-HT receptors, GABA receptors, and sodium channels) are involved in central sensitization. Inhibitory interneurones and descending modulatory control systems (green neurons) are dysfunctional after nerve lesions. (d) Peripheral nerve injury activates spinal cord glial cells (grey cell) via chemokines, such as CCL2, acting on chemokine receptors. Activated microglia further enhance excitability in second-order neurones by releasing cytokines and growth factors (e.g. tumour necrosis factor and bone-derived nerve factor) and increasing glutamate concentrations. CCL2, chemokine (C-C motif) ligand 2; KA, kainate; NE, norepinephrine; TRPV1, transient receptor potential V1; WDR, wide dynamic range. Figure reproduced with permission from Elsevier.23 British Journal of Anaesthesia 2016 117, ii95-ii106DOI: (10.1093/bja/aew212) Copyright © 2016 The Author(s) Terms and Conditions